SEND NEWS ARTICLE TO FRIEND
To Email:
From Email:
News Headline
Galectin Therapeutics Receives U.S. Patent for Potential Ground-Breaking Treatment for Chronic Liver Disease With Fibrosis (Scarring) and Cirrhosis